Treon, S. P., Soumerai, J. D., Hunter, Z. R., Patterson, C. J., Ioakimidis, L., Kahl, B., & Boxer, M. (2011). Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab. American Society of Hematology.
Citação norma ChicagoTreon, Steven P., Jacob D. Soumerai, Zachary R. Hunter, Christopher J. Patterson, Leukothea Ioakimidis, Brad Kahl, and Michael Boxer. Long-term Follow-up of Symptomatic Patients With Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Treated With the Anti-CD52 Monoclonal Antibody Alemtuzumab. American Society of Hematology, 2011.
MLA citiranjeTreon, Steven P., et al. Long-term Follow-up of Symptomatic Patients With Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Treated With the Anti-CD52 Monoclonal Antibody Alemtuzumab. American Society of Hematology, 2011.